Drug Shortage Report for RANITIDINE INJECTION USP
Report ID | 119246 |
Drug Identification Number | 02256711 |
Brand name | RANITIDINE INJECTION USP |
Common or Proper name | RANITIDINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 50ML |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2020-09-14 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2021-03-01 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-11-17 | French | Compare |
v8 | 2023-11-17 | English | Compare |
v7 | 2020-09-15 | French | Compare |
v6 | 2020-09-15 | English | Compare |
v5 | 2020-09-15 | French | Compare |
v4 | 2020-09-15 | English | Compare |
v3 | 2020-09-15 | English | Compare |
v2 | 2020-06-30 | French | Compare |
v1 | 2020-06-30 | English | Compare |
Showing 1 to 9 of 9